Global Hospital-Acquired Infections Assays Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Hospital-Acquired Infections Assays market size was valued at USD 4187.8 million in 2023 and is forecast to a readjusted size of USD 6676.7 million by 2030 with a CAGR of 6.9% during review period.
Hospital-acquired infections assays refer to diagnostic tests and assays designed to identify and detect infections that patients may acquire during their stay in healthcare facilities, such as hospitals. These assays play a crucial role in early and accurate diagnosis, enabling healthcare providers to implement timely interventions and prevent the spread of infections within healthcare settings.
The market for hospital-acquired infections assays is driven by the increasing awareness of the importance of infection control in healthcare settings. The assays include a variety of diagnostic tools, such as molecular assays, immunoassays, and microbial culture tests, providing a comprehensive approach to identifying and managing hospital-acquired infections. The need for rapid and accurate diagnostics to reduce the incidence of hospital-acquired infections contributes to the growth of this market.
The Global Info Research report includes an overview of the development of the Hospital-Acquired Infections Assays industry chain, the market status of Urinary Tract Infections (Blood Tests, Urinalysis), Pneumonia (Blood Tests, Urinalysis), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Hospital-Acquired Infections Assays.
Regionally, the report analyzes the Hospital-Acquired Infections Assays markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Hospital-Acquired Infections Assays market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Hospital-Acquired Infections Assays market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Hospital-Acquired Infections Assays industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Blood Tests, Urinalysis).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Hospital-Acquired Infections Assays market.
Regional Analysis: The report involves examining the Hospital-Acquired Infections Assays market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Hospital-Acquired Infections Assays market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Hospital-Acquired Infections Assays:
Company Analysis: Report covers individual Hospital-Acquired Infections Assays players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Hospital-Acquired Infections Assays This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Urinary Tract Infections, Pneumonia).
Technology Analysis: Report covers specific technologies relevant to Hospital-Acquired Infections Assays. It assesses the current state, advancements, and potential future developments in Hospital-Acquired Infections Assays areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Hospital-Acquired Infections Assays market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Hospital-Acquired Infections Assays market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Hospital-Acquired Infections Assays product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hospital-Acquired Infections Assays, with revenue, gross margin and global market share of Hospital-Acquired Infections Assays from 2019 to 2024.
Chapter 3, the Hospital-Acquired Infections Assays competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Hospital-Acquired Infections Assays market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hospital-Acquired Infections Assays.
Chapter 13, to describe Hospital-Acquired Infections Assays research findings and conclusion.
Hospital-acquired infections assays refer to diagnostic tests and assays designed to identify and detect infections that patients may acquire during their stay in healthcare facilities, such as hospitals. These assays play a crucial role in early and accurate diagnosis, enabling healthcare providers to implement timely interventions and prevent the spread of infections within healthcare settings.
The market for hospital-acquired infections assays is driven by the increasing awareness of the importance of infection control in healthcare settings. The assays include a variety of diagnostic tools, such as molecular assays, immunoassays, and microbial culture tests, providing a comprehensive approach to identifying and managing hospital-acquired infections. The need for rapid and accurate diagnostics to reduce the incidence of hospital-acquired infections contributes to the growth of this market.
The Global Info Research report includes an overview of the development of the Hospital-Acquired Infections Assays industry chain, the market status of Urinary Tract Infections (Blood Tests, Urinalysis), Pneumonia (Blood Tests, Urinalysis), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Hospital-Acquired Infections Assays.
Regionally, the report analyzes the Hospital-Acquired Infections Assays markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Hospital-Acquired Infections Assays market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Hospital-Acquired Infections Assays market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Hospital-Acquired Infections Assays industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Blood Tests, Urinalysis).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Hospital-Acquired Infections Assays market.
Regional Analysis: The report involves examining the Hospital-Acquired Infections Assays market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Hospital-Acquired Infections Assays market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Hospital-Acquired Infections Assays:
Company Analysis: Report covers individual Hospital-Acquired Infections Assays players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Hospital-Acquired Infections Assays This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Urinary Tract Infections, Pneumonia).
Technology Analysis: Report covers specific technologies relevant to Hospital-Acquired Infections Assays. It assesses the current state, advancements, and potential future developments in Hospital-Acquired Infections Assays areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Hospital-Acquired Infections Assays market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Hospital-Acquired Infections Assays market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Blood Tests
- Urinalysis
- Urinary Tract Infections
- Pneumonia
- Surgical Site Infections
- Bloodstream Infections
- Other Hospital Infections
- BIOMЙRIEUX
- Abbott
- F. Hoffmann-La Roche Ltd.
- Siemens Healthcare Private Limited
- BD (Becton, Dickinson and Company)
- Bioscience, Inc.
- QIAGEN
- Thermo Fisher Scientific Inc.
- Meridian Bioscience, Inc.
- Hologic, Inc.
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Hospital-Acquired Infections Assays product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hospital-Acquired Infections Assays, with revenue, gross margin and global market share of Hospital-Acquired Infections Assays from 2019 to 2024.
Chapter 3, the Hospital-Acquired Infections Assays competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Hospital-Acquired Infections Assays market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hospital-Acquired Infections Assays.
Chapter 13, to describe Hospital-Acquired Infections Assays research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Hospital-Acquired Infections Assays
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Hospital-Acquired Infections Assays by Type
1.3.1 Overview: Global Hospital-Acquired Infections Assays Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Hospital-Acquired Infections Assays Consumption Value Market Share by Type in 2023
1.3.3 Blood Tests
1.3.4 Urinalysis
1.4 Global Hospital-Acquired Infections Assays Market by Application
1.4.1 Overview: Global Hospital-Acquired Infections Assays Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Urinary Tract Infections
1.4.3 Pneumonia
1.4.4 Surgical Site Infections
1.4.5 Bloodstream Infections
1.4.6 Other Hospital Infections
1.5 Global Hospital-Acquired Infections Assays Market Size & Forecast
1.6 Global Hospital-Acquired Infections Assays Market Size and Forecast by Region
1.6.1 Global Hospital-Acquired Infections Assays Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Hospital-Acquired Infections Assays Market Size by Region, (2019-2030)
1.6.3 North America Hospital-Acquired Infections Assays Market Size and Prospect (2019-2030)
1.6.4 Europe Hospital-Acquired Infections Assays Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Hospital-Acquired Infections Assays Market Size and Prospect (2019-2030)
1.6.6 South America Hospital-Acquired Infections Assays Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Hospital-Acquired Infections Assays Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 BIOMЙRIEUX
2.1.1 BIOMЙRIEUX Details
2.1.2 BIOMЙRIEUX Major Business
2.1.3 BIOMЙRIEUX Hospital-Acquired Infections Assays Product and Solutions
2.1.4 BIOMЙRIEUX Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 BIOMЙRIEUX Recent Developments and Future Plans
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott Hospital-Acquired Infections Assays Product and Solutions
2.2.4 Abbott Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Abbott Recent Developments and Future Plans
2.3 F. Hoffmann-La Roche Ltd.
2.3.1 F. Hoffmann-La Roche Ltd. Details
2.3.2 F. Hoffmann-La Roche Ltd. Major Business
2.3.3 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product and Solutions
2.3.4 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
2.4 Siemens Healthcare Private Limited
2.4.1 Siemens Healthcare Private Limited Details
2.4.2 Siemens Healthcare Private Limited Major Business
2.4.3 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product and Solutions
2.4.4 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Siemens Healthcare Private Limited Recent Developments and Future Plans
2.5 BD (Becton, Dickinson and Company)
2.5.1 BD (Becton, Dickinson and Company) Details
2.5.2 BD (Becton, Dickinson and Company) Major Business
2.5.3 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product and Solutions
2.5.4 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 BD (Becton, Dickinson and Company) Recent Developments and Future Plans
2.6 Bioscience, Inc.
2.6.1 Bioscience, Inc. Details
2.6.2 Bioscience, Inc. Major Business
2.6.3 Bioscience, Inc. Hospital-Acquired Infections Assays Product and Solutions
2.6.4 Bioscience, Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bioscience, Inc. Recent Developments and Future Plans
2.7 QIAGEN
2.7.1 QIAGEN Details
2.7.2 QIAGEN Major Business
2.7.3 QIAGEN Hospital-Acquired Infections Assays Product and Solutions
2.7.4 QIAGEN Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 QIAGEN Recent Developments and Future Plans
2.8 Thermo Fisher Scientific Inc.
2.8.1 Thermo Fisher Scientific Inc. Details
2.8.2 Thermo Fisher Scientific Inc. Major Business
2.8.3 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product and Solutions
2.8.4 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.9 Meridian Bioscience, Inc.
2.9.1 Meridian Bioscience, Inc. Details
2.9.2 Meridian Bioscience, Inc. Major Business
2.9.3 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product and Solutions
2.9.4 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Meridian Bioscience, Inc. Recent Developments and Future Plans
2.10 Hologic, Inc.
2.10.1 Hologic, Inc. Details
2.10.2 Hologic, Inc. Major Business
2.10.3 Hologic, Inc. Hospital-Acquired Infections Assays Product and Solutions
2.10.4 Hologic, Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Hologic, Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Hospital-Acquired Infections Assays Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Hospital-Acquired Infections Assays by Company Revenue
3.2.2 Top 3 Hospital-Acquired Infections Assays Players Market Share in 2023
3.2.3 Top 6 Hospital-Acquired Infections Assays Players Market Share in 2023
3.3 Hospital-Acquired Infections Assays Market: Overall Company Footprint Analysis
3.3.1 Hospital-Acquired Infections Assays Market: Region Footprint
3.3.2 Hospital-Acquired Infections Assays Market: Company Product Type Footprint
3.3.3 Hospital-Acquired Infections Assays Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Hospital-Acquired Infections Assays Consumption Value and Market Share by Type (2019-2024)
4.2 Global Hospital-Acquired Infections Assays Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2019-2024)
5.2 Global Hospital-Acquired Infections Assays Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Hospital-Acquired Infections Assays Consumption Value by Type (2019-2030)
6.2 North America Hospital-Acquired Infections Assays Consumption Value by Application (2019-2030)
6.3 North America Hospital-Acquired Infections Assays Market Size by Country
6.3.1 North America Hospital-Acquired Infections Assays Consumption Value by Country (2019-2030)
6.3.2 United States Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
6.3.3 Canada Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
6.3.4 Mexico Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Hospital-Acquired Infections Assays Consumption Value by Type (2019-2030)
7.2 Europe Hospital-Acquired Infections Assays Consumption Value by Application (2019-2030)
7.3 Europe Hospital-Acquired Infections Assays Market Size by Country
7.3.1 Europe Hospital-Acquired Infections Assays Consumption Value by Country (2019-2030)
7.3.2 Germany Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
7.3.3 France Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
7.3.5 Russia Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
7.3.6 Italy Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Hospital-Acquired Infections Assays Market Size by Region
8.3.1 Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Region (2019-2030)
8.3.2 China Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
8.3.3 Japan Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
8.3.4 South Korea Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
8.3.5 India Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
8.3.7 Australia Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Hospital-Acquired Infections Assays Consumption Value by Type (2019-2030)
9.2 South America Hospital-Acquired Infections Assays Consumption Value by Application (2019-2030)
9.3 South America Hospital-Acquired Infections Assays Market Size by Country
9.3.1 South America Hospital-Acquired Infections Assays Consumption Value by Country (2019-2030)
9.3.2 Brazil Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
9.3.3 Argentina Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Hospital-Acquired Infections Assays Market Size by Country
10.3.1 Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Country (2019-2030)
10.3.2 Turkey Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
10.3.4 UAE Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Hospital-Acquired Infections Assays Market Drivers
11.2 Hospital-Acquired Infections Assays Market Restraints
11.3 Hospital-Acquired Infections Assays Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Hospital-Acquired Infections Assays Industry Chain
12.2 Hospital-Acquired Infections Assays Upstream Analysis
12.3 Hospital-Acquired Infections Assays Midstream Analysis
12.4 Hospital-Acquired Infections Assays Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Hospital-Acquired Infections Assays
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Hospital-Acquired Infections Assays by Type
1.3.1 Overview: Global Hospital-Acquired Infections Assays Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Hospital-Acquired Infections Assays Consumption Value Market Share by Type in 2023
1.3.3 Blood Tests
1.3.4 Urinalysis
1.4 Global Hospital-Acquired Infections Assays Market by Application
1.4.1 Overview: Global Hospital-Acquired Infections Assays Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Urinary Tract Infections
1.4.3 Pneumonia
1.4.4 Surgical Site Infections
1.4.5 Bloodstream Infections
1.4.6 Other Hospital Infections
1.5 Global Hospital-Acquired Infections Assays Market Size & Forecast
1.6 Global Hospital-Acquired Infections Assays Market Size and Forecast by Region
1.6.1 Global Hospital-Acquired Infections Assays Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Hospital-Acquired Infections Assays Market Size by Region, (2019-2030)
1.6.3 North America Hospital-Acquired Infections Assays Market Size and Prospect (2019-2030)
1.6.4 Europe Hospital-Acquired Infections Assays Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Hospital-Acquired Infections Assays Market Size and Prospect (2019-2030)
1.6.6 South America Hospital-Acquired Infections Assays Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Hospital-Acquired Infections Assays Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 BIOMЙRIEUX
2.1.1 BIOMЙRIEUX Details
2.1.2 BIOMЙRIEUX Major Business
2.1.3 BIOMЙRIEUX Hospital-Acquired Infections Assays Product and Solutions
2.1.4 BIOMЙRIEUX Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 BIOMЙRIEUX Recent Developments and Future Plans
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott Hospital-Acquired Infections Assays Product and Solutions
2.2.4 Abbott Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Abbott Recent Developments and Future Plans
2.3 F. Hoffmann-La Roche Ltd.
2.3.1 F. Hoffmann-La Roche Ltd. Details
2.3.2 F. Hoffmann-La Roche Ltd. Major Business
2.3.3 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product and Solutions
2.3.4 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
2.4 Siemens Healthcare Private Limited
2.4.1 Siemens Healthcare Private Limited Details
2.4.2 Siemens Healthcare Private Limited Major Business
2.4.3 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product and Solutions
2.4.4 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Siemens Healthcare Private Limited Recent Developments and Future Plans
2.5 BD (Becton, Dickinson and Company)
2.5.1 BD (Becton, Dickinson and Company) Details
2.5.2 BD (Becton, Dickinson and Company) Major Business
2.5.3 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product and Solutions
2.5.4 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 BD (Becton, Dickinson and Company) Recent Developments and Future Plans
2.6 Bioscience, Inc.
2.6.1 Bioscience, Inc. Details
2.6.2 Bioscience, Inc. Major Business
2.6.3 Bioscience, Inc. Hospital-Acquired Infections Assays Product and Solutions
2.6.4 Bioscience, Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bioscience, Inc. Recent Developments and Future Plans
2.7 QIAGEN
2.7.1 QIAGEN Details
2.7.2 QIAGEN Major Business
2.7.3 QIAGEN Hospital-Acquired Infections Assays Product and Solutions
2.7.4 QIAGEN Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 QIAGEN Recent Developments and Future Plans
2.8 Thermo Fisher Scientific Inc.
2.8.1 Thermo Fisher Scientific Inc. Details
2.8.2 Thermo Fisher Scientific Inc. Major Business
2.8.3 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product and Solutions
2.8.4 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.9 Meridian Bioscience, Inc.
2.9.1 Meridian Bioscience, Inc. Details
2.9.2 Meridian Bioscience, Inc. Major Business
2.9.3 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product and Solutions
2.9.4 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Meridian Bioscience, Inc. Recent Developments and Future Plans
2.10 Hologic, Inc.
2.10.1 Hologic, Inc. Details
2.10.2 Hologic, Inc. Major Business
2.10.3 Hologic, Inc. Hospital-Acquired Infections Assays Product and Solutions
2.10.4 Hologic, Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Hologic, Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Hospital-Acquired Infections Assays Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Hospital-Acquired Infections Assays by Company Revenue
3.2.2 Top 3 Hospital-Acquired Infections Assays Players Market Share in 2023
3.2.3 Top 6 Hospital-Acquired Infections Assays Players Market Share in 2023
3.3 Hospital-Acquired Infections Assays Market: Overall Company Footprint Analysis
3.3.1 Hospital-Acquired Infections Assays Market: Region Footprint
3.3.2 Hospital-Acquired Infections Assays Market: Company Product Type Footprint
3.3.3 Hospital-Acquired Infections Assays Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Hospital-Acquired Infections Assays Consumption Value and Market Share by Type (2019-2024)
4.2 Global Hospital-Acquired Infections Assays Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2019-2024)
5.2 Global Hospital-Acquired Infections Assays Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Hospital-Acquired Infections Assays Consumption Value by Type (2019-2030)
6.2 North America Hospital-Acquired Infections Assays Consumption Value by Application (2019-2030)
6.3 North America Hospital-Acquired Infections Assays Market Size by Country
6.3.1 North America Hospital-Acquired Infections Assays Consumption Value by Country (2019-2030)
6.3.2 United States Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
6.3.3 Canada Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
6.3.4 Mexico Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Hospital-Acquired Infections Assays Consumption Value by Type (2019-2030)
7.2 Europe Hospital-Acquired Infections Assays Consumption Value by Application (2019-2030)
7.3 Europe Hospital-Acquired Infections Assays Market Size by Country
7.3.1 Europe Hospital-Acquired Infections Assays Consumption Value by Country (2019-2030)
7.3.2 Germany Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
7.3.3 France Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
7.3.5 Russia Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
7.3.6 Italy Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Hospital-Acquired Infections Assays Market Size by Region
8.3.1 Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Region (2019-2030)
8.3.2 China Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
8.3.3 Japan Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
8.3.4 South Korea Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
8.3.5 India Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
8.3.7 Australia Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Hospital-Acquired Infections Assays Consumption Value by Type (2019-2030)
9.2 South America Hospital-Acquired Infections Assays Consumption Value by Application (2019-2030)
9.3 South America Hospital-Acquired Infections Assays Market Size by Country
9.3.1 South America Hospital-Acquired Infections Assays Consumption Value by Country (2019-2030)
9.3.2 Brazil Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
9.3.3 Argentina Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Hospital-Acquired Infections Assays Market Size by Country
10.3.1 Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Country (2019-2030)
10.3.2 Turkey Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
10.3.4 UAE Hospital-Acquired Infections Assays Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Hospital-Acquired Infections Assays Market Drivers
11.2 Hospital-Acquired Infections Assays Market Restraints
11.3 Hospital-Acquired Infections Assays Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Hospital-Acquired Infections Assays Industry Chain
12.2 Hospital-Acquired Infections Assays Upstream Analysis
12.3 Hospital-Acquired Infections Assays Midstream Analysis
12.4 Hospital-Acquired Infections Assays Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Hospital-Acquired Infections Assays Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Hospital-Acquired Infections Assays Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Hospital-Acquired Infections Assays Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Hospital-Acquired Infections Assays Consumption Value by Region (2025-2030) & (USD Million)
Table 5. BIOMЙRIEUX Company Information, Head Office, and Major Competitors
Table 6. BIOMЙRIEUX Major Business
Table 7. BIOMЙRIEUX Hospital-Acquired Infections Assays Product and Solutions
Table 8. BIOMЙRIEUX Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. BIOMЙRIEUX Recent Developments and Future Plans
Table 10. Abbott Company Information, Head Office, and Major Competitors
Table 11. Abbott Major Business
Table 12. Abbott Hospital-Acquired Infections Assays Product and Solutions
Table 13. Abbott Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Abbott Recent Developments and Future Plans
Table 15. F. Hoffmann-La Roche Ltd. Company Information, Head Office, and Major Competitors
Table 16. F. Hoffmann-La Roche Ltd. Major Business
Table 17. F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product and Solutions
Table 18. F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
Table 20. Siemens Healthcare Private Limited Company Information, Head Office, and Major Competitors
Table 21. Siemens Healthcare Private Limited Major Business
Table 22. Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product and Solutions
Table 23. Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Siemens Healthcare Private Limited Recent Developments and Future Plans
Table 25. BD (Becton, Dickinson and Company) Company Information, Head Office, and Major Competitors
Table 26. BD (Becton, Dickinson and Company) Major Business
Table 27. BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product and Solutions
Table 28. BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. BD (Becton, Dickinson and Company) Recent Developments and Future Plans
Table 30. Bioscience, Inc. Company Information, Head Office, and Major Competitors
Table 31. Bioscience, Inc. Major Business
Table 32. Bioscience, Inc. Hospital-Acquired Infections Assays Product and Solutions
Table 33. Bioscience, Inc. Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Bioscience, Inc. Recent Developments and Future Plans
Table 35. QIAGEN Company Information, Head Office, and Major Competitors
Table 36. QIAGEN Major Business
Table 37. QIAGEN Hospital-Acquired Infections Assays Product and Solutions
Table 38. QIAGEN Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. QIAGEN Recent Developments and Future Plans
Table 40. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
Table 41. Thermo Fisher Scientific Inc. Major Business
Table 42. Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product and Solutions
Table 43. Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Table 45. Meridian Bioscience, Inc. Company Information, Head Office, and Major Competitors
Table 46. Meridian Bioscience, Inc. Major Business
Table 47. Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product and Solutions
Table 48. Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Meridian Bioscience, Inc. Recent Developments and Future Plans
Table 50. Hologic, Inc. Company Information, Head Office, and Major Competitors
Table 51. Hologic, Inc. Major Business
Table 52. Hologic, Inc. Hospital-Acquired Infections Assays Product and Solutions
Table 53. Hologic, Inc. Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Hologic, Inc. Recent Developments and Future Plans
Table 55. Global Hospital-Acquired Infections Assays Revenue (USD Million) by Players (2019-2024)
Table 56. Global Hospital-Acquired Infections Assays Revenue Share by Players (2019-2024)
Table 57. Breakdown of Hospital-Acquired Infections Assays by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Hospital-Acquired Infections Assays, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Hospital-Acquired Infections Assays Players
Table 60. Hospital-Acquired Infections Assays Market: Company Product Type Footprint
Table 61. Hospital-Acquired Infections Assays Market: Company Product Application Footprint
Table 62. Hospital-Acquired Infections Assays New Market Entrants and Barriers to Market Entry
Table 63. Hospital-Acquired Infections Assays Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Hospital-Acquired Infections Assays Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Hospital-Acquired Infections Assays Consumption Value Share by Type (2019-2024)
Table 66. Global Hospital-Acquired Infections Assays Consumption Value Forecast by Type (2025-2030)
Table 67. Global Hospital-Acquired Infections Assays Consumption Value by Application (2019-2024)
Table 68. Global Hospital-Acquired Infections Assays Consumption Value Forecast by Application (2025-2030)
Table 69. North America Hospital-Acquired Infections Assays Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Hospital-Acquired Infections Assays Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Hospital-Acquired Infections Assays Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Hospital-Acquired Infections Assays Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Hospital-Acquired Infections Assays Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Hospital-Acquired Infections Assays Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Hospital-Acquired Infections Assays Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Hospital-Acquired Infections Assays Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Hospital-Acquired Infections Assays Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Hospital-Acquired Infections Assays Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Hospital-Acquired Infections Assays Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Hospital-Acquired Infections Assays Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Hospital-Acquired Infections Assays Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Hospital-Acquired Infections Assays Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Hospital-Acquired Infections Assays Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Hospital-Acquired Infections Assays Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Hospital-Acquired Infections Assays Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Hospital-Acquired Infections Assays Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Hospital-Acquired Infections Assays Raw Material
Table 100. Key Suppliers of Hospital-Acquired Infections Assays Raw Materials
Table 1. Global Hospital-Acquired Infections Assays Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Hospital-Acquired Infections Assays Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Hospital-Acquired Infections Assays Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Hospital-Acquired Infections Assays Consumption Value by Region (2025-2030) & (USD Million)
Table 5. BIOMЙRIEUX Company Information, Head Office, and Major Competitors
Table 6. BIOMЙRIEUX Major Business
Table 7. BIOMЙRIEUX Hospital-Acquired Infections Assays Product and Solutions
Table 8. BIOMЙRIEUX Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. BIOMЙRIEUX Recent Developments and Future Plans
Table 10. Abbott Company Information, Head Office, and Major Competitors
Table 11. Abbott Major Business
Table 12. Abbott Hospital-Acquired Infections Assays Product and Solutions
Table 13. Abbott Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Abbott Recent Developments and Future Plans
Table 15. F. Hoffmann-La Roche Ltd. Company Information, Head Office, and Major Competitors
Table 16. F. Hoffmann-La Roche Ltd. Major Business
Table 17. F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product and Solutions
Table 18. F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
Table 20. Siemens Healthcare Private Limited Company Information, Head Office, and Major Competitors
Table 21. Siemens Healthcare Private Limited Major Business
Table 22. Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product and Solutions
Table 23. Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Siemens Healthcare Private Limited Recent Developments and Future Plans
Table 25. BD (Becton, Dickinson and Company) Company Information, Head Office, and Major Competitors
Table 26. BD (Becton, Dickinson and Company) Major Business
Table 27. BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product and Solutions
Table 28. BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. BD (Becton, Dickinson and Company) Recent Developments and Future Plans
Table 30. Bioscience, Inc. Company Information, Head Office, and Major Competitors
Table 31. Bioscience, Inc. Major Business
Table 32. Bioscience, Inc. Hospital-Acquired Infections Assays Product and Solutions
Table 33. Bioscience, Inc. Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Bioscience, Inc. Recent Developments and Future Plans
Table 35. QIAGEN Company Information, Head Office, and Major Competitors
Table 36. QIAGEN Major Business
Table 37. QIAGEN Hospital-Acquired Infections Assays Product and Solutions
Table 38. QIAGEN Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. QIAGEN Recent Developments and Future Plans
Table 40. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
Table 41. Thermo Fisher Scientific Inc. Major Business
Table 42. Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product and Solutions
Table 43. Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Table 45. Meridian Bioscience, Inc. Company Information, Head Office, and Major Competitors
Table 46. Meridian Bioscience, Inc. Major Business
Table 47. Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product and Solutions
Table 48. Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Meridian Bioscience, Inc. Recent Developments and Future Plans
Table 50. Hologic, Inc. Company Information, Head Office, and Major Competitors
Table 51. Hologic, Inc. Major Business
Table 52. Hologic, Inc. Hospital-Acquired Infections Assays Product and Solutions
Table 53. Hologic, Inc. Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Hologic, Inc. Recent Developments and Future Plans
Table 55. Global Hospital-Acquired Infections Assays Revenue (USD Million) by Players (2019-2024)
Table 56. Global Hospital-Acquired Infections Assays Revenue Share by Players (2019-2024)
Table 57. Breakdown of Hospital-Acquired Infections Assays by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Hospital-Acquired Infections Assays, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Hospital-Acquired Infections Assays Players
Table 60. Hospital-Acquired Infections Assays Market: Company Product Type Footprint
Table 61. Hospital-Acquired Infections Assays Market: Company Product Application Footprint
Table 62. Hospital-Acquired Infections Assays New Market Entrants and Barriers to Market Entry
Table 63. Hospital-Acquired Infections Assays Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Hospital-Acquired Infections Assays Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Hospital-Acquired Infections Assays Consumption Value Share by Type (2019-2024)
Table 66. Global Hospital-Acquired Infections Assays Consumption Value Forecast by Type (2025-2030)
Table 67. Global Hospital-Acquired Infections Assays Consumption Value by Application (2019-2024)
Table 68. Global Hospital-Acquired Infections Assays Consumption Value Forecast by Application (2025-2030)
Table 69. North America Hospital-Acquired Infections Assays Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Hospital-Acquired Infections Assays Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Hospital-Acquired Infections Assays Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Hospital-Acquired Infections Assays Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Hospital-Acquired Infections Assays Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Hospital-Acquired Infections Assays Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Hospital-Acquired Infections Assays Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Hospital-Acquired Infections Assays Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Hospital-Acquired Infections Assays Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Hospital-Acquired Infections Assays Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Hospital-Acquired Infections Assays Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Hospital-Acquired Infections Assays Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Hospital-Acquired Infections Assays Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Hospital-Acquired Infections Assays Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Hospital-Acquired Infections Assays Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Hospital-Acquired Infections Assays Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Hospital-Acquired Infections Assays Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Hospital-Acquired Infections Assays Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Hospital-Acquired Infections Assays Raw Material
Table 100. Key Suppliers of Hospital-Acquired Infections Assays Raw Materials
LIST OF FIGURES
Figure 1. Hospital-Acquired Infections Assays Picture
Figure 2. Global Hospital-Acquired Infections Assays Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Hospital-Acquired Infections Assays Consumption Value Market Share by Type in 2023
Figure 4. Blood Tests
Figure 5. Urinalysis
Figure 6. Global Hospital-Acquired Infections Assays Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Hospital-Acquired Infections Assays Consumption Value Market Share by Application in 2023
Figure 8. Urinary Tract Infections Picture
Figure 9. Pneumonia Picture
Figure 10. Surgical Site Infections Picture
Figure 11. Bloodstream Infections Picture
Figure 12. Other Hospital Infections Picture
Figure 13. Global Hospital-Acquired Infections Assays Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Hospital-Acquired Infections Assays Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Hospital-Acquired Infections Assays Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Hospital-Acquired Infections Assays Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Hospital-Acquired Infections Assays Consumption Value Market Share by Region in 2023
Figure 18. North America Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Hospital-Acquired Infections Assays Revenue Share by Players in 2023
Figure 24. Hospital-Acquired Infections Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Hospital-Acquired Infections Assays Market Share in 2023
Figure 26. Global Top 6 Players Hospital-Acquired Infections Assays Market Share in 2023
Figure 27. Global Hospital-Acquired Infections Assays Consumption Value Share by Type (2019-2024)
Figure 28. Global Hospital-Acquired Infections Assays Market Share Forecast by Type (2025-2030)
Figure 29. Global Hospital-Acquired Infections Assays Consumption Value Share by Application (2019-2024)
Figure 30. Global Hospital-Acquired Infections Assays Market Share Forecast by Application (2025-2030)
Figure 31. North America Hospital-Acquired Infections Assays Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Hospital-Acquired Infections Assays Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Hospital-Acquired Infections Assays Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Hospital-Acquired Infections Assays Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 41. France Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value Market Share by Region (2019-2030)
Figure 48. China Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 51. India Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Hospital-Acquired Infections Assays Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Hospital-Acquired Infections Assays Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Hospital-Acquired Infections Assays Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Hospital-Acquired Infections Assays Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 65. Hospital-Acquired Infections Assays Market Drivers
Figure 66. Hospital-Acquired Infections Assays Market Restraints
Figure 67. Hospital-Acquired Infections Assays Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Hospital-Acquired Infections Assays in 2023
Figure 70. Manufacturing Process Analysis of Hospital-Acquired Infections Assays
Figure 71. Hospital-Acquired Infections Assays Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Hospital-Acquired Infections Assays Picture
Figure 2. Global Hospital-Acquired Infections Assays Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Hospital-Acquired Infections Assays Consumption Value Market Share by Type in 2023
Figure 4. Blood Tests
Figure 5. Urinalysis
Figure 6. Global Hospital-Acquired Infections Assays Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Hospital-Acquired Infections Assays Consumption Value Market Share by Application in 2023
Figure 8. Urinary Tract Infections Picture
Figure 9. Pneumonia Picture
Figure 10. Surgical Site Infections Picture
Figure 11. Bloodstream Infections Picture
Figure 12. Other Hospital Infections Picture
Figure 13. Global Hospital-Acquired Infections Assays Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Hospital-Acquired Infections Assays Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Hospital-Acquired Infections Assays Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Hospital-Acquired Infections Assays Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Hospital-Acquired Infections Assays Consumption Value Market Share by Region in 2023
Figure 18. North America Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Hospital-Acquired Infections Assays Revenue Share by Players in 2023
Figure 24. Hospital-Acquired Infections Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Hospital-Acquired Infections Assays Market Share in 2023
Figure 26. Global Top 6 Players Hospital-Acquired Infections Assays Market Share in 2023
Figure 27. Global Hospital-Acquired Infections Assays Consumption Value Share by Type (2019-2024)
Figure 28. Global Hospital-Acquired Infections Assays Market Share Forecast by Type (2025-2030)
Figure 29. Global Hospital-Acquired Infections Assays Consumption Value Share by Application (2019-2024)
Figure 30. Global Hospital-Acquired Infections Assays Market Share Forecast by Application (2025-2030)
Figure 31. North America Hospital-Acquired Infections Assays Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Hospital-Acquired Infections Assays Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Hospital-Acquired Infections Assays Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Hospital-Acquired Infections Assays Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 41. France Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value Market Share by Region (2019-2030)
Figure 48. China Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 51. India Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Hospital-Acquired Infections Assays Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Hospital-Acquired Infections Assays Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Hospital-Acquired Infections Assays Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Hospital-Acquired Infections Assays Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Hospital-Acquired Infections Assays Consumption Value (2019-2030) & (USD Million)
Figure 65. Hospital-Acquired Infections Assays Market Drivers
Figure 66. Hospital-Acquired Infections Assays Market Restraints
Figure 67. Hospital-Acquired Infections Assays Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Hospital-Acquired Infections Assays in 2023
Figure 70. Manufacturing Process Analysis of Hospital-Acquired Infections Assays
Figure 71. Hospital-Acquired Infections Assays Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
